Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Lake Street analyst Frank Takkinen maintains $LENSAR(LNSR.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 34.2% and a total a

moomoo NewsJun 5 09:33 ET

LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of catara

BusinesswireMay 23 08:00 ET

US$8.00: That's What Analysts Think LENSAR, Inc. (NASDAQ:LNSR) Is Worth After Its Latest Results

It's been a pretty great week for LENSAR, Inc. (NASDAQ:LNSR) shareholders, with its shares surging 16% to US$3.78 in the week since its latest quarterly results. It looks like the results were

Simply Wall StMay 12 08:24 ET

LENSAR | 10-Q: Quarterly report

SEC announcementMay 9 16:05 ET · Announcements

Earnings Flash (LNSR) LENSAR Reports Q1 Revenue $10.6M

07:13 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (LNSR) LENSAR Reports Q1 Revenue $10.6M

MT NewswiresMay 9 07:13 ET

LENSAR Q1 2024 GAAP EPS $(0.19) Beats $(0.28) Estimate, Sales $10.588M Beat $10.550M Estimate

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.28) by 32.14 percent. This is a 52.5 percent increase over losses of $(0.40) per sh

BenzingaMay 9 07:13 ET